Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Asensus Surgical Inc’s stock clocked out at $0.33, up 0.54% from its previous closing price of $0.33. In other words, the price has increased by $0.54 from its previous closing price. On the day, 0.94 million shares were traded. ASXC stock price reached its highest trading level at $0.33595 during the session, while it also had its lowest trading level at $0.33.
Ratios:
To gain a deeper understanding of ASXC’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.69 and its Current Ratio is at 1.00. In the meantime, Its Debt-to-Equity ratio is 0.42 whereas as Long-Term Debt/Eq ratio is at 0.34.
On September 08, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $1.50.
On May 26, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $4.H.C. Wainwright initiated its Buy rating on May 26, 2021, with a $4 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 14 ’23 when Starling William N JR bought 18,134 shares for $0.28 per share. The transaction valued at 5,078 led to the insider holds 39,134 shares of the business.
Starling William N JR sold 18,134 shares of ASXC for $5,078 on Dec 14 ’23. The Director now owns 0 shares after completing the transaction at $0.28 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ASXC now has a Market Capitalization of 91432536 and an Enterprise Value of 88861512. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.42 while its Price-to-Book (P/B) ratio in mrq is 6.96. Its current Enterprise Value per Revenue stands at 10.186 whereas that against EBITDA is -1.264.
Stock Price History:
Over the past 52 weeks, ASXC has reached a high of $0.65, while it has fallen to a 52-week low of $0.20. The 50-Day Moving Average of the stock is 21.26%, while the 200-Day Moving Average is calculated to be 21.95%.
Shares Statistics:
It appears that ASXC traded 2.62M shares on average per day over the past three months and 2495900 shares per day over the past ten days. A total of 272.54M shares are outstanding, with a floating share count of 267.03M. Insiders hold about 2.02% of the company’s shares, while institutions hold 9.11% stake in the company. Shares short for ASXC as of 1718323200 were 11473282 with a Short Ratio of 4.38, compared to 1715731200 on 14397300. Therefore, it implies a Short% of Shares Outstanding of 11473282 and a Short% of Float of 4.3.
Earnings Estimates
The performance of Asensus Surgical Inc (ASXC) in the stock market is under the watchful eye of 2.0 analysts actively contributing to its current rating.On average, analysts expect EPS of -$0.06 for the current quarter, with a high estimate of -$0.05 and a low estimate of -$0.07, while EPS last year was -$0.09. The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.04 and low estimates of -$0.07.
Analysts are recommending an EPS of between -$0.21 and -$0.27 for the fiscal current year, implying an average EPS of -$0.24. EPS for the following year is -$0.19, with 2.0 analysts recommending between -$0.13 and -$0.25.
Revenue Estimates
For the next quarter, 2 analysts are estimating revenue of $3.55M. There is a high estimate of $5.8M for the next quarter, whereas the lowest estimate is $1.3M.
A total of 2 analysts have provided revenue estimates for ASXC’s current fiscal year. The highest revenue estimate was $14.32M, while the lowest revenue estimate was $9.8M, resulting in an average revenue estimate of $12.06M. In the same quarter a year ago, actual revenue was $8.58MBased on 2 analysts’ estimates, the company’s revenue will be $21.91M in the next fiscal year. The high estimate is $31.52M and the low estimate is $12.3M.
